Skip to main content

Table 7 Cost effectiveness analysis of SMC (US $ 2016)

From: Cost-effectiveness of district-wide seasonal malaria chemoprevention when implemented through routine malaria control programme in Kita, Mali using fixed point distribution

  Mean Lower 95% limita Higher 95% limit
Costs Per Episode Averted    
 Financial cost per childhood episode averted (actual coverage) 3.77 2.50 6.34
 Economic cost per childhood episode averted (actual coverage) 4.26 2.83 7.17
 Financial cost per childhood episode averted (predicted coverage) 5.07 3.36 8.53
 Economic cost per childhood episode averted (predicted coverage) 5.74 3.80 9.65
 Financial cost per all ages episode averted (predicted coverage) 4.35 2.92 7.26
 Economic cost per all ages episode averted (predicted coverage) 4.92 3.31 8.21
Economic Cost per DALY averted (actual coverage) 144 135 153
Economic Cost per Death averted (actual coverage) 14,503 13,604 15,402
  1. aUncertainty bounds – for cost per episode these were taken from the ranges of the model effectiveness estimates. For the DALYs and Deaths a ± 20% was used in the absence of any cost uncertainty, a gamma distribution was assumed for all parameters and 10,000 iterations were run using monte carlo simulations